Antifungal Agents

Sep 20, 2016 by in HEMATOLOGY Comments Off on Antifungal Agents

Fig. 15.1 Targets of systemic antifungal agents Clinical outcomes in susceptible isolates are best predicted by the peak serum level to MIC ratio. Serum drug levels are infrequently measured and…

read more

Infections in Patients with Malignant Lymphomas

Sep 20, 2016 by in HEMATOLOGY Comments Off on Infections in Patients with Malignant Lymphomas

Bacterial pathogens Streptococcus pneumoniae Haemophilus influenzae Neisseria meningitidis Nocardia species Salmonella species Listeria monocytogenes Campylobacter species Legionella species Capnocytophaga species Mycobacteria Fungal pathogens Aspergillus species Zygomycetes (Mucorales) Fusarium species Scedosporium…

read more

Consequences from Specific Treatment Modalities

Sep 20, 2016 by in HEMATOLOGY Comments Off on Consequences from Specific Treatment Modalities

L. monocytogenes a S. pneumoniae Staphylococcus spp. Pseudomonas spp. Gram-negative aerobic bacilli N. meningitidis Candida spp. b Aspergillus spp. Cryptococcus neoformans b Varicella zoster virusc Herpes simplex virusc Cytomegalovirus P….

read more

Microbiological Background

Sep 20, 2016 by in HEMATOLOGY Comments Off on Microbiological Background

Fig. 5.1 Frequency of single-agent bacteremia in IATC-EORTC trials Since the turn of the twenty-first century, the reports emerged indicating that GNB have gained importance again but this time with…

read more

Antimicrobial Prophylaxis in Hematology

Sep 20, 2016 by in HEMATOLOGY Comments Off on Antimicrobial Prophylaxis in Hematology

Type of prophylaxis and clinical condition Recommendation and gradinga Antibacterial prophylaxis Patients with acute leukemia and adult SCT recipients after myeloablative therapy A fluoroquinolone with systemic activity including P. aeruginosa…

read more
Get Clinical Tree app for offline access